METHOD OF DETERMINING RISK OF DEATH IN REMOTE PERIOD AFTER MYOCARDIAL INFARCTION Russian patent published in 2013 - IPC A61B5/02 A61B10/00 G01N33/48 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to cardiology. When patient with acute myocardial infarction (AMI) is hospitalised, their ECG is registered, clinical and biochemical blood tests are performed, and anamnesis is analysed. The following parameters are analysed: HB higher than 77/min for men or HB higher than 80/min for women on ECG at rest in lying position, presence of signs of hypertrophy of left ventricle myocardium (HLV), presence of ST-T changes and presence of complete left block of bundle of His, presence of myocardial infarction (MI) in anamnesis, complicated course of acute MI, presence of diabetes mellitus, low socio-economic status, determined by the level of the average monthly income below living wage; treatment with beta-blockers, ACE inhibitors, calcium antagonists before acute MI and antiplatelet agents during hospitalisation; increased ESR higher than 15 mm/hour for men and 21 mm/h for women, increased level of K+ higher than 5.3 mmol/l, reduction of K+ lower than 3.5, pulse in sitting position more than 80/min during physical examination in the process of hospitalisation. Index of risk of death in remote period after MI (MINDEX) is calculated by elaborated mathematical formula. Risk of death is estimated as very low, low, medium, high, very high by MINDEX value.

EFFECT: method makes it possible to determine risk of death in remote period after MI.

2 ex